A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection
Clinical trial NCT00000812 · COMPLETED
Trial details
- NCT number
- NCT00000812
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.